Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Becton Dickinson (BDX) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareBDX

Latest price · Nov 20, 2026 $214.28 +0.8% on the day · +47.4% over 12 months 52-week range $139.89 – $218.03
Get BDX alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling5last 12 months
Reported sales$3.4M21 of 24 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.

Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Feb 4, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Thomas E. Polen Jr., CEO, President sold 2,993 shares at $210.00 ($629K).

Trade date
Nov 5, 2026
Disclosed to the SEC
Nov 9, 2026
Type
Pre-planned sale, 10b5-1 (code S)

Read the original SEC filing ↗All BDX insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

BDX insider transactions (Form 4)

Open-market purchases and sales. 58 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Nov 9SEC Thomas E. Polen Jr.CEO, President Sell Plan 2,993110,163 held (−3%) $210.00 $629K +2.0% —
Oct 27SEC Michael FeldEvp, Chief Revenue Officer Sell Plan 7619,568 held (−0%) $198.13 $15K +8.2% —
Sep 29SEC Michael FeldEvp, Chief Revenue Officer Sell Plan 7619,644 held (−0%) $183.70 $14K +16.6% —
Aug 27SEC Michael FeldEvp, Chief Revenue Officer Sell Plan 16519,720 held (−1%) $188.49 $31K +13.7% —
Aug 14SEC Thomas E. Polen Jr.CEO, President Sell Plan 4,152110,163 held (−4%) $185.00 $768K +15.8% —
Aug 12SEC Roland GoettePresident Sell 2,43814,856 held (−14%) $180.84 $441K +18.5% —
Jul 28SEC Michael FeldEvp, Chief Revenue Officer Sell Plan 7520,934 held (−0%) $157.13 $12K +36.4% —
Jun 26SEC Michael FeldEvp, Chief Revenue Officer Sell Plan 7521,009 held (−0%) $152.80 $11K +40.2% —
Jun 25SEC Michael David GarrisonEvp & Pres Med.Essntl&Biopharm Sell Plan 1,10013,172 held (−8%) $145.66 $160K +47.1% —
Jun 11SEC Michael David GarrisonEvp & Pres Med.Essntl&Biopharm Sell Plan 1,10014,272 held (−7%) $151.48 $167K +41.5% —
Jun 3SEC Thomas E. Polen Jr.CEO, President Sell Plan 2,764110,163 held (−2%) $146.35 $405K +46.4% —
May 27SEC Michael FeldEvp, Chief Revenue Officer Sell Plan 7521,084 held (−0%) $147.35 $11K +45.4% —
Apr 28SEC Michael FeldEvp, Chief Revenue Officer Sell Plan 7421,159 held (−0%) $151.94 $11K +41.0% —
Mar 27SEC Michael FeldEvp, Chief Revenue Officer Sell Plan 7521,233 held (−0%) $156.83 $12K +36.6% —
Feb 27SEC Michael FeldEvp, Chief Revenue Officer Sell Plan 7521,308 held (−0%) $181.84 $14K +17.8% —
Feb 18SEC Bertram L. ScottDirector Sell 95336,763 held (−3%) $182.61 $174K +17.3% —
Jan 28SEC Michael FeldEvp, Cro & Pres. Life Sciences Sell Plan 7516,431 held (−0%) $202.73 $15K +5.7% —
Jan 16SEC Michael David GarrisonEvp & Pres Med.Essntl&Biopharm Sell Plan 1,01012,095 held (−8%) $206.54 $209K +3.7% —
Jan 16SEC Michael David GarrisonEvp & Pres Med.Essntl&Biopharm Sell Plan 60013,105 held (−4%) $209.00 $125K +2.5% —
Dec 29SEC Michael FeldEvp, Cro & Pres. Life Sciences Sell Plan 7416,506 held (−0%) $196.08 $15K +9.3% —
Dec 17SEC Michael David GarrisonEvp & Pres Med.Essntl&Biopharm Sell Plan 62913,105 held (−5%) $196.03 $123K +9.3% —
Dec 2SEC Michael FeldEvp, Cro & Pres. Life Sciences Sell Plan 7516,580 held (−0%) $193.36 $15K +10.8% —
Nov 7SEC Bertram L. ScottDirector Sell 21735,816 held (−1%) $176.58 $38K +21.4% —
Oct 28SEC Michael FeldPresident Sell Plan 578,245 held (−1%) $186.01 $11K +15.2% —
Historical context

Similar past setups: not applicable. BDX has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with BDX in the Research Lab

BDX has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

BDX closeInsider buyInsider sale
125150175200225DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-09EEarnings release filed 2026-04-02EEarnings release filed 2026-05-07EEarnings release filed 2026-08-06EEarnings release filed 2026-11-05Sold $11,051 on 2026-05-26 · Michael FeldSold $11,244 on 2026-04-27 · Michael FeldSold $11,460 on 2026-06-26 · Michael FeldSold $11,762 on 2026-03-26 · Michael FeldSold $11,785 on 2026-07-27 · Michael FeldSold $13,638 on 2026-02-26 · Michael FeldSold $13,961 on 2026-09-28 · Michael FeldSold $14,502 on 2025-12-01 · Michael FeldSold $14,510 on 2025-12-26 · Michael FeldSold $15,058 on 2026-10-26 · Michael FeldSold $15,205 on 2026-01-26 · Michael FeldSold $31,101 on 2026-08-26 · Michael FeldSold $123,303 on 2025-12-17 · Michael David GarrisonSold $160,226 on 2026-06-24 · Michael David GarrisonSold $166,628 on 2026-06-10 · Michael David GarrisonSold $174,027 on 2026-02-18 · Bertram L. ScottSold $334,005 on 2026-01-15 · Michael David GarrisonSold $404,511 on 2026-06-01 · Thomas E. Polen Jr.Sold $440,888 on 2026-08-11 · Roland GoetteSold $628,530 on 2026-11-05 · Thomas E. Polen Jr.Sold $768,120 on 2026-08-13 · Thomas E. Polen Jr.
Bought, 12 months$0
Sold, 12 months$3.4M
Insiders buying0
Insiders selling5

Becton Dickinson insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $3.4M of BDX stock on the open market; P/E 41.3 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

BDX insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $201K sold (5 trades)Q4 2025Q1 2026: $549K sold (6 trades)Q1 2026Q2 2026: $765K sold (6 trades)Q2 2026Q3 2026: $1.3M sold (5 trades)Q3 2026Q4 2026: $644K sold (2 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$644K2
Q3 2026—0$1.3M5
Q2 2026—0$765K6
Q1 2026—0$549K6
Q4 2025—0$201K5

Valuation, profit and volume

P/E (trailing)41.3Sector median 25.0
Volume vs. 50-day0.9×Last 5 sessions

Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 Becton Dickinson insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $3.4M. 21 of 24 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

BDX earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Nov 5, 2026 +7.9% Sold $15K +1.3%S&P -4.1% pending
Aug 6, 2026 +10.9% Sold $12K +3.6%S&P +0.5% +4.5%
May 7, 2026 -7.6% Sold $11K +3.2%S&P +0.5% +1.2%
Apr 2, 2026 -3.3% Sold $12K -0.7%S&P +0.6% -6.8%
Feb 9, 2026 +1.9% Sold $349K +4.0%S&P +0.2% -6.4%
Nov 6, 2025 -6.7% Sold $11K +0.8%S&P -1.0% +9.1%
Oct 15, 2025 +2.4% None -1.6%S&P -0.2% +4.2%
Aug 7, 2025 -4.9% None +12.2%S&P +0.7% -0.6%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

BDX short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 39% of volume sold short2026-08-27: 52% of volume sold short2026-08-28: 61% of volume sold short2026-08-31: 62% of volume sold short2026-09-01: 64% of volume sold short2026-09-02: 64% of volume sold short2026-09-03: 50% of volume sold short2026-09-04: 53% of volume sold short2026-09-08: 63% of volume sold short2026-09-09: 69% of volume sold short2026-09-10: 50% of volume sold short2026-09-11: 42% of volume sold short2026-09-14: 69% of volume sold short2026-09-15: 66% of volume sold short2026-09-16: 66% of volume sold short2026-09-17: 56% of volume sold short2026-09-18: 42% of volume sold short2026-09-21: 48% of volume sold short2026-09-22: 54% of volume sold short2026-09-23: 58% of volume sold short2026-09-24: 38% of volume sold short2026-09-25: 35% of volume sold short2026-09-28: 38% of volume sold short2026-09-29: 44% of volume sold short2026-09-30: 40% of volume sold short2026-10-01: 41% of volume sold short2026-10-02: 50% of volume sold short2026-10-05: 26% of volume sold short2026-10-06: 23% of volume sold short2026-10-07: 36% of volume sold short2026-10-08: 45% of volume sold short2026-10-09: 39% of volume sold short2026-10-12: 37% of volume sold short2026-10-13: 46% of volume sold short2026-10-14: 38% of volume sold short2026-10-15: 31% of volume sold short2026-10-16: 49% of volume sold short2026-10-19: 41% of volume sold short2026-10-20: 35% of volume sold short2026-10-21: 55% of volume sold short2026-10-22: 50% of volume sold short2026-10-23: 42% of volume sold short2026-10-26: 30% of volume sold short2026-10-27: 31% of volume sold short2026-10-28: 21% of volume sold short2026-10-29: 40% of volume sold short2026-10-30: 43% of volume sold short2026-11-02: 29% of volume sold short2026-11-03: 32% of volume sold short2026-11-04: 36% of volume sold short2026-11-05: 43% of volume sold short2026-11-06: 48% of volume sold short2026-11-09: 36% of volume sold short2026-11-10: 50% of volume sold short2026-11-11: 47% of volume sold short2026-11-12: 57% of volume sold short2026-11-13: 56% of volume sold short2026-11-16: 48% of volume sold short2026-11-17: 58% of volume sold short2026-11-18: 52% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 52%20-day average: 42%Prior 2 months: 47%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded BDX

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 +40.5%

Insiders at Becton Dickinson

InsiderBoughtSoldLast filingPast buys beat S&PScore
Thomas E. Polen Jr.CEO, President — $1.8M Nov 9, 2026 — —
Michael David GarrisonEvp & Pres Med.Essntl&Biopharm — $784K Jun 25, 2026 — —
Roland GoettePresident — $441K Aug 12, 2026 — —
Bertram L. ScottDirector — $212K Feb 18, 2026 — —
Michael FeldEvp, Chief Revenue Officer — $186K Oct 27, 2026 — —
Vitor RoqueCFO — — Sep 3, 2026 — —
Bilal MuhsinPresident — — Jul 6, 2026 — —
Peter MenziusoPresident — — Jun 2, 2026 — —
Shana Carol NealEvp And Chief People Officer — — Apr 6, 2026 — —
Lanesha MinnixGeneral Counsel — — Mar 17, 2026 — —
Pamela L. SpiknerSvp Controller & Cao — — Mar 4, 2026 — —
Jacqueline WrightDirector — — Jan 29, 2026 — —
Joanne WaldstreicherDirector — — Jan 29, 2026 — —
Timothy M. RingDirector — — Jan 29, 2026 — —
Christopher Ian Montague JonesDirector — — Jan 29, 2026 — —
Robert Luther HuffinesDirector — — Jan 29, 2026 — —
William M. BrownDirector — — Jan 29, 2026 — —
Gregory HayesDirector — — Jan 29, 2026 0 of 1 —
Carrie L. ByingtonDirector — — Jan 29, 2026 — —
R. Andrew EckertDirector — — Jan 29, 2026 — —
Jeffrey William HendersonDirector — — Jan 29, 2026 0 of 1 —
David ShanEvp And Chief Isc Officer — — Jan 6, 2026 — —
Richard ByrdPresident — — Dec 1, 2025 — —
Christopher DeloreficeCFO — — Dec 1, 2025 — —
Pavan Kumar MocherlaPresident — — Dec 1, 2025 — —

Board links: companies that share insiders with BDX

Directors and executives who filed Form 4s for BDX and another company in the last 12 months.

See the map →
  • AEISAdvanced Energy Industries Lanesha Minnix General Counsel here · Director at AEIS · latest filing Nov 17, 2026
  • DGXQuest Diagnostics Timothy M. Ring Director here · Director at DGX · latest filing May 21, 2026
  • EQHEquitable Holdings Bertram L. Scott Director here · Director at EQH · latest filing Sep 21, 2026
  • MMM3M William M. Brown Director here · CEO, Chair at MMM · latest filing May 4, 2026
  • PODDInsulet Robert Luther Huffines Director here · Director at PODD · latest filing Oct 2, 2026
  • PSXPhillips 66 Gregory Hayes Director here · Director at PSX · latest filing Jan 29, 2026
  • QCOMQualcomm Jeffrey William Henderson Director here · Director at QCOM · latest filing Mar 18, 2026
  • RMDResMed Christopher Delorefice CFO here · Director at RMD · latest filing Dec 1, 2025
  • ULTAUlta Beauty Christopher Delorefice CFO here · CFO at ULTA · latest filing Apr 2, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

BDX stock: common questions

Are Becton Dickinson insiders buying BDX stock?

No. No Becton Dickinson insider reported an open-market purchase of BDX in the past 12 months.

Are Becton Dickinson insiders selling BDX stock?

5 insiders reported sales worth $3.4M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is BDX's P/E ratio?

BDX trades at about 41.3 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is BDX's 52-week range?

Over the past year BDX has traded between $139.89 and $218.03. It last closed at $214.28 on Nov 20, 2026.